Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Irinotecan disrupts tight junction proteins within the gut: implications for chemotherapy-induced gut toxicityWardill, H.; Bowen, J.; Al-Dasooqi, N.; Sultani, M.; Bateman, E.; Stansborough, R.; Shirren, J.; Gibson, R.
2015Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities an emerging hypothesis for neuropathy and gastrointestinal toxicityWardill, H.; Van Sebille, Y.; Mander, K.; Gibson, R.; Logan, R.; Bowen, J.; Sonis, S.
2016Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanismsWardill, H.; Gibson, R.; Van Sebille, Y.; Secombe, K.; Coller, J.; White, I.; Manavis, J.; Hutchinson, M.; Staikopoulos, V.; Logan, R.; Bowen, J.
2016A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic optionsWardill, H.; Gibson, R.; Van Sebille, Y.; Secombe, K.; Logan, R.; Bowen, J.
2016Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancerWardill, H.; Logan, R.; Bowen, J.; Van Sebille, Y.; Gibson, R.
2016Chemotherapy-induced gut toxicity and pain: involvement of TLRsGibson, R.; Coller, J.; Wardill, H.; Hutchinson, M.; Smid, S.; Bowen, J.
2016Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunctionWardill, H.; Mander, K.; Van Sebille, Y.; Gibson, R.; Logan, R.; Bowen, J.; Sonis, S.
2017Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in ratsVan Sebille, Y.; Gibson, R.; Wardill, H.; Secombe, K.; Ball, I.; Keefe, D.; Finnie, J.; Bowen, J.